PMV Pharma

PMV Pharmaceuticals Inc is a precision oncology company. The company is engaged in the research and development of small molecule, tumor-agnostic therapies targeting p53 mutations, which has the ability to eliminate cancer cells.

News

Penny Stocks

Small Cap

Intraday Update

Markets

Movers

Trading Ideas

BLPH

BPTH

BSFC

BYSI

CELU

CISS

CMTL

CTHR

EDSA

GRPN

HRMY

LGMK

LIFW

NUWE

OBLG

OTLK

PCSA

PMVP

PSQH

RBBN

RDHL

RERE

RSLS

SASI

SAVA

SECO

SNCR

SOPA

STAF

STKL

STRL

TIRX

TNGX

VSAT

Gainers


	Sigma Additive Solutions, Inc.  (NASDAQ: SASI) shares jumped 196% to $7.34 after the company announced the signing of a definitive agreement for the acquisition of NextTrip Holdings, Inc.


Why Belden Shares Are Trading Lower By Over 25%? Here Are Other Stocks Moving In Friday&#39;s Mid-Day Session

Biotech

Health Care

General

PMV Pharmaceuticals Inc (NASDAQ: PMVP) announced updated Phase 1 results from its ongoing Phase 1/2 PYNNACLE trial that showed PC14586 achieved efficacy in heavily pretreated patients across multiple tumor types and was well tolerated with a 

Precision Oncology PMV Pharmaceuticals Reveals Early Data From Cancer Study In Pretreated Patients

AMTI

AONC

ATEX

AVTX

CETX

CLDI

CONNEXA SPORTS TECH INC by Connexa Sports Technologies Inc.

CNXA

CPTN

ELUT

FEAM

FFIE

FISK

FLUX

GLBS

HSCS

ICPT

MDBH

MKUL

MLGO

MOND

MORF

MURF

NEPT

NXPL

PBTS

PHAR

SCHL

SNPX

STTK

SWIN

TIGR

UPTD

VNRX

Gainers

MicroAlgo Inc.  (NASDAQ: MLGO) shares jumped 74% to $7.02 after it unveiled a knowledge-enhanced backtracking search algorithm to boost the performance and efficiency of research institutions.

Why Flux Power Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday&#39;s Mid-Day Session

PMV Pharmaceuticals Inc

Earnings

Press Releases

PMV Pharmaceuticals Reports First Quarter 2024 Financial Results and Corporate Highlights

Foundation Medicine and PMV Pharma Announce Collaboration to Develop Companion Diagnostic for Rezatapopt, a First-In-Class, Investigational, Selective p53 Y220C Reactivator

PMV Pharmaceuticals to Participate at Upcoming Investor Conferences in June

PMV Pharmaceuticals Reports Second Quarter 2024 Financial Results and Provides a Progress Update on PYNNACLE Clinical Trial

"Game-Changing Biotech Companies Making Waves: INBS, PMVP, TPST, OMGA, MRSN"

PMV Pharmaceuticals Provides a Progress Update on PYNNACLE Clinical Trial

PMV Pharmaceuticals Reports Third Quarter 2024 Financial Results

PMV Pharmaceuticals to Participate at Upcoming Investor Conferences

PMV Pharmaceuticals Reports Full Year 2024 Financial Results and Corporate Highlights

INBS

MRSN

OMGA

TPST

Aadi Bioscience

Acumen Pharmaceuticals, Inc. - Common Stock

Acumen Pharmaceuticals

Adicet Bio

Agenus

Armata Pharmaceuticals, Inc. Common Stock

Armata Pharmaceuticals

Aerovate Therapeutics, Inc. - Common Stock

Aerovate Therapeutics

Avalo Therapeutics

Burning Rock Biotech Limited - American Depositary Shares

Burning Rock Biotech

BeyondSpring

Cibus

Cue Biopharma

Genenta Science S.p.A. - American Depositary Shares

Genenta Science

I-MAB

Inovio Pharmaceuticals, Inc. - Common Stock

Inovio Pharmaceuticals

Inozyme Pharma

Karyopharm Therapeutics Inc. - Common Stock

Karyopharm Therapeutics

Metagenomi

Mersana Therapeutics, Inc. - Common Stock

Mersana Therapeutics

OnKure Therapeutics, Inc. - Class A Common Stock

OnKure Therapeutics

Pyxis Oncology

Quince Therapeutics

Shattuck Labs

Tenaya Therapeutics

Vistagen Therapeutics, Inc. - Common Stock

Vistagen Therapeutics

X4 Pharmaceuticals

HC Wainwright & Co.

Craig-Hallum

Jefferies

Ladenburg Thalmann

Oppenheimer

Comments

PMV Pharma

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga